Pharmaceutical products are regarded as materials with manufacturing processes within the context of our analytical methods and devices rather than medical compounds with healing and therapeutical characteristics. Galenics and pharmaceutical technologies produce pharmaceutical agents in their final delivery form, which means the task is to characterize a powder, dispersion or pill. This means, pharmaceutical research and development is part of our field of applications where both of our analytical methods for dispersions (such as stability of dispersions) as well as texture analysis (such as BET surface area of powders) and pore analysis (such as pore structure of pills) are required.
| ANALYSYS METHOD | PARAMETER | MEASURING INSTRUMENT |
|---|---|---|
| Multiple light scattering | Stability of dispersions | Contract analysis |
| Gas adsorption | BET-surface area and pore analysis | 3P micro series 3P meso series 3P sync series 3P surface DX |
| Mercury porosimetry | Pore analysis (pore volume, pore size distribution, raw density) | Contract analysis |
| Dynamic vapor sorption – DVS | Water uptake and -release | 3P graviSorb series |
| Gas pycnometry | Density | 3P densi series |
| Laser diffraction (wet or dry) | Particle size of powders | Bettersizer S3 series Bettersizer 2600 Bettersizer ST |
| Image analysis | Particle shape | BeVision D2 Bettersizer S3 Plus |
| DLS – dynamic light scattering (Photon correlation) | Particle size in nanometer ranges | BeNano series |
| Acoustic spectrometry | Particle size in micrometer and nanometer ranges in concentrated dispersions | DT-1202 DT-100 |
| Electro acoustics | Zeta potential | DT-1202 DT-310 DT-300 |
Deutsch
English